Workflow
CH ENV TECH & BIO(01237)
icon
Search documents
中科生物(01237) - 2019 - 年度财报
2020-04-27 22:37
Financial Performance - Revenue for the year ended December 31, 2019, was RMB 694,052,000, an increase of 9.4% from RMB 634,686,000 in 2018[8] - Gross profit decreased significantly to RMB 8,624,000, resulting in a gross profit margin of 1.2%, down from 10.8% in the previous year[8] - The net loss for 2019 was RMB 64,471,000, improving from a net loss of RMB 184,931,000 in 2018, with a net profit margin of -9.29%[8] - The Group recorded a loss of RMB 64.5 million for the year, a significant decrease from the loss of approximately RMB 184.9 million in 2018, primarily due to no significant additional impairment of assets required in 2019[18] - The impairment of assets recognized in 2018 amounted to approximately RMB 139.3 million, which was not repeated in 2019[18] - The Group anticipates challenges in profitability due to external factors such as the global economic slowdown and the COVID-19 outbreak[23] - The Group's overall profitability is expected to be under pressure due to various unfavorable external and domestic factors affecting asset and inventory returns[25] Assets and Liabilities - Current assets decreased to RMB 454,973,000 from RMB 618,361,000 in 2018, while current liabilities reduced to RMB 89,234,000 from RMB 197,862,000[8] - Total assets as of 31 December 2019 were RMB 981.4 million, down from RMB 1,167.9 million in 2018[15] - Total liabilities decreased to RMB 95.8 million in 2019 from RMB 217.3 million in 2018[15] - Non-current assets decreased to RMB 526,472,000 from RMB 549,520,000 in 2018, reflecting a reduction in long-term investments[8] - The equity attributable to equity shareholders decreased to RMB 885,633,000 from RMB 950,548,000 in 2018, indicating a decline in shareholder equity[8] Revenue Breakdown - The manufacturing and sales of wooden products generated revenue of approximately RMB 687.1 million, an increase of 11.0% from RMB 618.9 million in 2018, accounting for 99.0% of total revenue[29][30][33] - Revenue from the renewable energy products segment decreased by 52.7% to approximately RMB 6.9 million, down from RMB 14.6 million in 2018, with profit dropping to RMB 0.9 million from RMB 2.5 million[29][36] - Revenue from North America grew by 28.6% to RMB334.4 million, accounting for 48% of total revenue, up from 41% in 2018[40][41] - Revenue from the PRC market fell by 23.6% to RMB111.6 million, representing 16% of total revenue, down from 23% in 2018[43][45] - Overall revenue from leisure household products surged by 36.9% to RMB72.1 million, with outdoor and indoor furniture increasing by 90.7%[49][53] Market Challenges - The increase in trade tariffs imposed by the United States from 10% to 25% effective May 2019 further declined the profit margin of wooden products exported to the U.S.[19] - The North American market remains the largest income stream for the Group, but trade tensions have adversely impacted performance[19] - The Group anticipates that external factors, including the COVID-19 outbreak and economic slowdowns, will negatively impact profitability in the first half of 2020[25] Corporate Governance - The company has complied with all applicable corporate governance code provisions throughout the year, except for certain disclosed deviations[109] - The Board of Directors is responsible for major decisions, including overall strategies and annual budgets, and is expected to meet at least four times a year[111][122] - The Board consists of two executive directors and four non-executive directors, with three of the non-executive directors being independent[125] - The company is committed to maintaining high standards of corporate governance to enhance transparency and accountability to shareholders[108] Employee and Remuneration - Total employee remuneration expenses for the year were RMB35.3 million, representing 5.1% of the Group's revenue[95] - The Group employed 464 full-time employees as of December 31, 2019, an increase from 426 in 2018[95] - The remuneration for executive Directors and senior management is determined based on performance, professional experience, and prevailing market practices[147] Risk Management - The Risk Management Committee, comprising all independent non-executive Directors, is responsible for reviewing the Group's risk management framework and material risk exposures[196][198] - The Directors acknowledge their responsibility for preparing financial statements that present a true and fair view in accordance with International Financial Reporting Standards[200] COVID-19 Impact - The outbreak of COVID-19 in January 2020 may impact the Group's financial results, although the extent cannot be estimated at this time[104] - The Group will take proactive measures to minimize the impact of COVID-19 on its financial position and operating results[104] - The ongoing COVID-19 pandemic may further affect the company's financial performance, although the extent of this impact is currently unquantifiable[106]
中科生物(01237) - 2019 - 中期财报
2019-09-20 09:09
Financial Performance - The Group achieved a revenue growth of 13.3% to RMB 384.0 million compared to RMB 314.0 million in the same period last year[12]. - The gross profit decreased significantly to RMB 13.3 million, resulting in a gross profit margin of 3.5%, down from 17.4% in the previous year[12]. - The Group recorded a net loss of RMB 14.7 million, compared to a profit of RMB 10.5 million in the same period last year, leading to a net profit margin of -4.0%[12]. - The overall revenue from all business segments amounted to approximately RMB 384.0 million, a 22.3% increase from RMB 313.9 million in the previous year[29]. - The Group recorded a loss of approximately RMB 14.7 million for the period, compared to a profit of RMB 10.5 million in H1 2018[52]. - Loss for the period was RMB 14,673,000, a significant decline from a profit of RMB 10,518,000 in the same period of 2018[131]. - Total comprehensive loss for the period was RMB 16,318,000, compared to a total comprehensive income of RMB 10,311,000 in the previous year[131]. Revenue Breakdown - Revenue from the manufacturing and sales of wooden products increased by 25.2% to RMB 380.4 million, contributing 99.0% of the total revenue[21]. - Revenue from timber houses and related parts was RMB 317.4 million, a significant increase from RMB 230.7 million in the previous year[12]. - Revenue from the renewable energy segment decreased by 63.7% to approximately RMB 3.4 million, with profit down to RMB 0.45 million[24]. - The retail business segment generated revenue of RMB 0.22 million, a decrease of 73.4% compared to RMB 0.82 million in the previous year[18]. - Revenue from the PRC market fell by 28.8% to RMB 57.1 million, accounting for 15% of total revenue[29]. - North America accounted for 55% of the total revenue, with revenue growing by 60.6% to RMB 212.6 million[29]. - Revenue from the China market decreased by 63.9% to RMB 29.0 million, representing 15% of total revenue, down from 26% in H1 2018[31]. - Australasia market maintained its position as the second largest income stream, contributing 23% of total revenue, with a 21.0% growth to RMB 89.0 million[33]. Asset Management - Non-current assets stood at RMB 546.9 million, while current assets decreased to RMB 513.3 million[12]. - The current ratio improved to 4.9:1 from 3.1:1, indicating better short-term financial health[12]. - Inventory turnover days decreased to 165 days from 218 days, reflecting improved inventory management[12]. - Trade receivables turnover days improved to 54 days from 65 days, indicating faster collection of receivables[12]. - Current assets decreased to RMB 513,272,000 from RMB 618,361,000 at the end of 2018, reflecting a decline of 18.0%[133]. - Total equity as of June 30, 2019, was RMB 934,230,000, down from RMB 950,548,000 at the end of 2018[134]. Operational Challenges - The Group's operating results were impacted by intensified trade conflicts, affecting overall profitability[15]. - The US-China trade dispute has negatively impacted the gross profit margin of the Group's products exported to the United States[22]. - The trade dispute between the US and China has created significant uncertainty and adverse impacts on the Group's business prospects, particularly affecting profit margins on products exported to the US[72]. - The Group plans to enhance product competitiveness and monitor market trends closely due to expected adverse effects on profitability[29]. Cost Management - Administrative expenses decreased to RMB 22.5 million, down from RMB 25.3 million in H1 2018, due to tightened cost control[49]. - The Group's financing costs decreased to approximately RMB 2.0 million during the period, down from RMB 3.8 million in the first half of 2018[56]. Capital Expenditure and Financing - Capital expenditure for property, plant, and equipment during the period was RMB 10.8 million, an increase from RMB 4.3 million in the first half of 2018[61]. - The total bank financing available to the Group was RMB 226.4 million as of June 30, 2019, compared to RMB 237.2 million at the end of 2018[59]. - The Group had no significant capital commitments or contingent liabilities as of June 30, 2019[62]. Shareholding and Corporate Governance - As of June 30, 2019, Mr. Wu Zheyan holds 449,647,412 shares, representing a 14.56% interest in the company[94]. - The Company has complied with the principles set out in the Corporate Governance Code, except for code provision C.1.2[115]. - The Board has resolved not to declare any interim dividend for the Period[114]. Accounting Policies and Standards - The company has maintained its accounting policies consistent with those adopted in the 2018 annual financial statements, with expected changes to be reflected in the 2019 annual financial statements[142]. - The group adopted IFRS 16, which requires all leases to be capitalized, excluding short-term leases and low-value asset leases[162]. - The initial application of IFRS 16 was effective from January 1, 2019, with the cumulative effect recognized as an adjustment to the opening balance of equity[155]. - The auditor's report on the financial statements was unqualified, indicating no significant issues were raised[148].
中科生物(01237) - 2018 - 年度财报
2019-04-18 08:49
Financial Performance - Revenue for 2018 reached RMB 634,686,000, a 37.2% increase from RMB 462,191,000 in 2017[10] - Gross profit for 2018 was RMB 68,525,000, with a gross profit margin of 10.8%, up from 7.0% in 2017[10] - The net loss for 2018 was RMB 184,931,000, resulting in a net profit margin of -29.1%, compared to -8.8% in 2017[10] - The loss attributable to shareholders increased to RMB 185 million in 2018, up from RMB 40.6 million in 2017, primarily due to weakened profitability from exports and asset impairment[18] - The Group recorded a net loss of RMB 184.9 million for the year, compared to a loss of RMB 40.6 million in 2017, reflecting a significant increase in losses[66] Asset Management - Non-current assets decreased to RMB 549,520,000 in 2018 from RMB 772,335,000 in 2017[10] - Current assets also declined to RMB 618,361,000 in 2018 from RMB 721,148,000 in 2017[10] - Total assets decreased to RMB 1,167,881 thousand in 2018 from RMB 1,493,483 thousand in 2017, while total liabilities decreased to RMB 217,333 thousand from RMB 362,893 thousand[16] - The Group recognizes the need for asset impairment of production facilities and lease prepayments due to ongoing trade tensions affecting profitability[36] Financial Ratios - The current ratio improved to 3.1:1 in 2018 from 2.2:1 in 2017, indicating better short-term financial health[10] - Total borrowings to total assets ratio decreased to 9.3% in 2018 from 16.7% in 2017, indicating reduced leverage[10] - The ratio of total borrowings to total assets was 9.3%, down from 16.7% in 2017, while the current ratio improved to 3.1:1 from 2.2:1[75] Revenue Breakdown - The manufacturing and sales of wooden products generated revenue of approximately RMB618.9 million, an increase of 41.7% from RMB436.8 million in 2017, accounting for 97.5% of total revenue[31] - Revenue from renewable energy products decreased by 27.5% to approximately RMB14.6 million, with profit declining by 29.1% to approximately RMB2.5 million, primarily due to intense domestic competition[38] - Revenue from the North American market grew by 10.1% to RMB260.1 million, accounting for 41% of total revenue (2017: 51%)[44] - Revenue from the PRC market increased by 36.1% to RMB146.1 million, representing 23% of total revenue, driven by growth in timber trading[43] - Australasia market revenue surged by 125.5% to RMB187.9 million, now accounting for 29% of total revenue (2017: 18%)[46] Market Challenges - The US-China trade dispute led to a 10% tariff on 5,745 types of imported goods, significantly impacting the Group's export business to the US[19] - The Group anticipates continued challenges in 2019 due to uncertainties from the US-China trade war and economic conditions in overseas markets[24] - The group anticipates continued challenges in the operating environment for 2019, influenced by the US-China trade dispute and other global economic uncertainties[27] Operational Strategies - The company plans to focus on expanding its renewable energy product line and enhancing its market presence[10] - New product development initiatives are underway to improve the range of leisure household products and timber-related offerings[10] - The retail business aims to improve operations through better cost controls and potential realignment of business direction[40] Employee Management - The Group employed a total of 426 full-time employees as of December 31, 2018, down from 510 in 2017[99] - Total employee compensation expenses for the year amounted to RMB 35.5 million, up from RMB 32.6 million in 2017, representing 5.6% of the group's revenue compared to 7.1% in 2017[102] - The company has maintained a competitive compensation package for employees, including discretionary bonuses and social insurance contributions[102] Corporate Governance - The board of directors consists of two executive directors and four non-executive directors, with three non-executive directors being independent[122] - The company has complied with all applicable code provisions in the Corporate Governance Code throughout the year, except for certain disclosed deviations[106] - The Audit Committee is responsible for overseeing financial reporting, risk management, and internal control systems, and is composed of independent non-executive Directors[154][158] Risk Management - The Risk Management Committee is composed entirely of independent non-executive directors, focusing on risk management and oversight of the company's risk policies and standards[192] - The committee reviews the group's major risk exposures, including market, credit, operational, and liquidity risks, ensuring compliance with risk measurement methodologies[194] - The company acknowledges its responsibility for preparing financial statements that present a true and fair view in accordance with International Financial Reporting Standards[196]